According to an article published today in The Boston Globe, the Dana-Farber Cancer Center and Brigham and Women’s Hospital are working together to initiate development of a very large, cancer-specific, genetic and clinical database. … READ MORE …
Filed under: Diagnosis, Management, Risk, Treatment | Tagged: Brigham and Women's, clinical, Dana-Farber, database, genetic, tumor | Leave a comment »
A new review by Epstein, currently available on line in the Journal of Urology, provides a detailed analysis of the clinical significance of various factors in determining prognostic risk for newly diagnosed and recently treated patients with localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: biopsy, clinical, core, pathologic, prognosis, quantification, stage, T2, tumor, volume | 10 Comments »
A new article in the May issue of Cancer Epidemiology, Biomarkers and Prevention appears to be a first attempt to project population-based probabilities of the occurrence of clinically significant prostate cancer among men who are diagnosed with prostate cancer but who receive no treatment. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Uncategorized | Tagged: clinical, Diagnosis, insignificant, probability, risk, significant | 5 Comments »
According to a new report from the University of California, San Francisco (to be published in Cancer this week), clinical staging errors may — at least in part — underlie the fact that the researchers were unable to demonstrate a clear link between clinical stage and risk for prostate cancer recurrence in patients initially diagnosed with localized prostate cancer. … READ MORE …
Filed under: Diagnosis, Management, Treatment | Tagged: accuracy, clinical, Diagnosis, prognosis, relevance, stage | 2 Comments »
Prostate cancer reports from the 50th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), being held in Boston, are kindly provided by Eyad Abu-Isa, MD, a resident in radiation oncology at the University of Michigan.
This afternoon, new and updated data from three large Phase III clinical trials were presented at the ASTRO plenary session and clinical updates section. … READ MORE …
Filed under: Management, Treatment | Tagged: antiandrogens, clinical, radiotherapy, trials | 2 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 